Immunomodulatory and anti‐inflammatory potential of crocin in COVID‐19 treatment

The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the p...

Full description

Saved in:
Bibliographic Details
Published inJournal of Food Biochemistry Vol. 45; no. 5; pp. e13718 - n/a
Main Author Ghasemnejad‐Berenji, Morteza
Format Journal Article Web Resource
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.05.2021
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS‐CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF‐κB expression which leads to a wide range of immunomodulatory and anti‐inflammatory effects, and (d) crocin can reduce the viral‐induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS‐CoV2 infection. Practical applications Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS‐CoV2 infection because of its antioxidant and anti‐inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS‐Cov‐2 infection. Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury
AbstractList Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury
The current COVID-19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS-CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF-κB expression which leads to a wide range of immunomodulatory and anti-inflammatory effects, and (d) crocin can reduce the viral-induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS-CoV2 infection. PRACTICAL APPLICATIONS: Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS-CoV2 infection because of its antioxidant and anti-inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS-CoV2-induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS-Cov-2 infection.
The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS‐CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF‐κB expression which leads to a wide range of immunomodulatory and anti‐inflammatory effects, and (d) crocin can reduce the viral‐induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS‐CoV2 infection. Practical applications Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS‐CoV2 infection because of its antioxidant and anti‐inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS‐Cov‐2 infection. Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury
Author Ghasemnejad‐Berenji, Morteza
AuthorAffiliation 1 Department of Pharmacology and Toxicology School of Pharmacy Urmia University of Medical Sciences Urmia Iran
AuthorAffiliation_xml – name: 1 Department of Pharmacology and Toxicology School of Pharmacy Urmia University of Medical Sciences Urmia Iran
Author_xml – sequence: 1
  givenname: Morteza
  orcidid: 0000-0001-5672-9202
  surname: Ghasemnejad‐Berenji
  fullname: Ghasemnejad‐Berenji, Morteza
  email: morteza.ghasemnejad@yahoo.com
  organization: Urmia University of Medical Sciences
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33817822$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9KxDAQxoMourt68QGk4E1YTZq0SS-C1n8rwl5Wr2GapNqlbda0VfbmI_iMPolZu4peDBMSJj--mck3RJu1rQ1C-wQfE79O5nmmjgnlRGygAeEsGrOIsE00wMTfhRBsBw2bZo4xDpOYbaMdSgXhIgwHaDapqq62ldVdCa11ywBq7XdbfLy9F3VeQlX1-YVtjU9DGdg8UM6qog58pNOHyYVnSRK0zkBbeWgXbeVQNmZvfY7Q_dXlLL0Z302vJ-nZ3VgxJsSYaW6yJNFUxxEzkIFSMahYRAyAJgISDoKTJA4T0FFMQ8KpwnHOQRssNDA6Qqe97qLLKqOVL-2glAtXVOCW0kIh_77UxZN8tC9ShBHGMfUCh2sBZ58707RybjtX-56lJwQXOPTYCB31lJ-6aZzJfyoQLFcOyJUD8ssBDx_87ukH_f5yD5AeeC1Ks_xHSt5enae96CdBt5Xo
CitedBy_id crossref_primary_10_1111_bcp_16124
crossref_primary_10_1055_a_2132_4984
crossref_primary_10_3389_fimmu_2023_1127358
crossref_primary_10_3390_ijerph192315823
crossref_primary_10_3390_ijms25063194
crossref_primary_10_1155_2021_7352938
crossref_primary_10_3390_antiox11081551
crossref_primary_10_1016_j_biopha_2022_113297
crossref_primary_10_1007_s00210_022_02262_y
crossref_primary_10_1016_j_metop_2021_100111
crossref_primary_10_1186_s43014_023_00138_z
crossref_primary_10_1515_jbcpp_2022_0028
crossref_primary_10_1016_j_mad_2022_111686
crossref_primary_10_1177_09603271231169911
crossref_primary_10_1007_s10876_023_02526_4
crossref_primary_10_1038_s41392_022_01249_8
crossref_primary_10_1016_j_jep_2021_114555
crossref_primary_10_1111_jfbc_14345
crossref_primary_10_1515_jbcpp_2021_0349
crossref_primary_10_3390_molecules27186005
crossref_primary_10_2139_ssrn_4110412
crossref_primary_10_1111_jfbc_14219
Cites_doi 10.3390/molecules25092076
10.1016/j.fct.2020.111521
10.1016/j.mehy.2020.110102
10.1155/2017/1702967
10.1186/s12931-018-0766-3
10.1086/656044
10.3390/antiox9060518
10.1016/j.arcmed.2020.04.019
10.1016/j.lfs.2019.116794
10.1002/jcb.26335
10.1111/bph.15157
ContentType Journal Article
Web Resource
Copyright 2021 Wiley Periodicals LLC.
2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com
Copyright_xml – notice: 2021 Wiley Periodicals LLC.
– notice: 2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com
DBID NPM
AAYXX
CITATION
COVID
5PM
DOI 10.1111/jfbc.13718
DatabaseName PubMed
CrossRef
Coronavirus Research Database
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Coronavirus Research Database
DatabaseTitleList
PubMed

Coronavirus Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: COVID
  name: Coronavirus Research Database
  url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Economics
Diet & Clinical Nutrition
DocumentTitleAlternate GHASEMNEJAD‐BERENJI
EISSN 1745-4514
EndPage n/a
ExternalDocumentID 10_1111_jfbc_13718
33817822
JFBC13718
Genre commentary
Journal Article
Commentary
GroupedDBID .3N
.GA
.Y3
05W
0R~
10A
169
1OB
1OC
24P
29K
31~
33P
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5HH
5LA
5VS
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
8VB
930
A03
A8Z
AAESR
AAEVG
AAHBH
AAHHS
AAJEY
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACKIV
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFPWT
AFZJQ
AHEFC
AIURR
AIWBW
AJBDE
AJXKR
AKVCP
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CAG
COF
CS3
D-E
D-F
D-I
DC6
DCZOG
DPXWK
DR2
DRFUL
DROCM
DRSTM
DU5
EBO
EBS
EBU
EJD
ESTFP
F00
F01
F04
F5P
FEDTE
FZ0
G-S
G.N
G8K
GODZA
H.T
H.X
H13
HF~
HVGLF
HZI
HZ~
I-F
J0M
K1G
K48
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QWB
R.K
RHX
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TH9
UB1
UCJ
W8V
W99
WBFHL
WBKPD
WIH
WIK
WOHZO
WQJ
WRC
WXSBR
WYISQ
XG1
ZL0
ZZTAW
~IA
~KM
~WT
NPM
AAYXX
CITATION
COVID
5PM
ID FETCH-LOGICAL-c4488-4d7eb99d3d654eabacc6ac6854aa398a97a8719629ad5632173c06f7ade08da43
IEDL.DBID COVID
ISSN 0145-8884
IngestDate Tue Sep 17 20:44:47 EDT 2024
Thu Oct 10 19:45:05 EDT 2024
Fri Aug 23 02:15:19 EDT 2024
Wed Oct 16 00:43:24 EDT 2024
Sat Aug 24 01:05:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords COVID-19
NF-κB
SARS-CoV2
crocin
Nrf2
PPARγ
Language English
License 2021 Wiley Periodicals LLC.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4488-4d7eb99d3d654eabacc6ac6854aa398a97a8719629ad5632173c06f7ade08da43
ORCID 0000-0001-5672-9202
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8250063
PMID 33817822
PQID 2508780206
PQPubID 4686273
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8250063
proquest_journals_2508780206
crossref_primary_10_1111_jfbc_13718
pubmed_primary_33817822
wiley_primary_10_1111_jfbc_13718_JFBC13718
PublicationCentury 2000
PublicationDate May 2021
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: May 2021
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of Food Biochemistry
PublicationTitleAlternate J Food Biochem
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
References 2018; 19
2020; 25
2019; 235
2020; 177
2017; 2017
2020; 51
2018; 119
2019; 22
2020; 143
2010; 202
2020; 9
e_1_2_4_10_1
e_1_2_4_11_1
e_1_2_4_12_1
e_1_2_4_3_1
e_1_2_4_2_1
e_1_2_4_5_1
Zeinali M. (e_1_2_4_13_1) 2019; 22
e_1_2_4_4_1
e_1_2_4_7_1
e_1_2_4_6_1
e_1_2_4_9_1
e_1_2_4_8_1
References_xml – volume: 19
  start-page: 58
  issue: 1
  year: 2018
  article-title: Crocin attenuates cigarette smoke‐induced lung injury and cardiac dysfunction by anti‐oxidative effects: The role of Nrf2 antioxidant system in preventing oxidative stress
  publication-title: Respiratory Research
– volume: 235
  year: 2019
  article-title: Crocin attenuates lung inflammation and pulmonary vascular dysfunction in a rat model of bleomycin‐induced pulmonary fibrosis
  publication-title: Life Sciences
– volume: 2017
  start-page: 1
  year: 2017
  end-page: 11
  article-title: The hepatoprotective and MicroRNAs downregulatory effects of crocin following hepatic ischemia‐reperfusion injury in rats
  publication-title: Oxidative Medicine and Cellular Longevity
– volume: 25
  start-page: 2076
  issue: 9
  year: 2020
  article-title: Pharmacological (or synthetic) and nutritional agonists of PPAR‐γ as candidates for cytokine storm modulation in COVID‐19 disease
  publication-title: Molecules
– volume: 177
  start-page: 4967
  issue: 21
  year: 2020
  end-page: 4970
  article-title: The potential of cannabidiol in the COVID‐19 pandemic
  publication-title: British Journal of Pharmacology
– volume: 9
  start-page: 518
  issue: 6
  year: 2020
  article-title: Nrf2 activator PB125® as a potential therapeutic agent against COVID‐19
  publication-title: Antioxidants
– volume: 119
  start-page: 1746
  issue: 2
  year: 2018
  end-page: 1754
  article-title: Crocin reduces ‐induced airway inflammation and NF‐κB signal activation
  publication-title: Journal of Cellular Biochemistry
– volume: 22
  start-page: 334
  issue: 4
  year: 2019
  article-title: Immunoregulatory and anti‐inflammatory properties of (Saffron) and its main active constituents: A review
  publication-title: Iranian Journal of Basic Medical Sciences
– volume: 51
  start-page: 384
  issue: 5
  year: 2020
  end-page: 387
  article-title: Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS‐CoV) infection
  publication-title: Archives of Medical Research
– volume: 143
  start-page: 111521
  year: 2020
  article-title: Crocin: A fighter against inflammation and pain
  publication-title: Food and Chemical Toxicology
– volume: 143
  start-page: 110102
  year: 2020
  article-title: SARS‐CoV‐2 infection pathogenesis is related to oxidative stress as a response to aggression
  publication-title: Medical Hypotheses
– volume: 202
  start-page: 991
  issue: 7
  year: 2010
  end-page: 1001
  article-title: Influenza virus—cytokine‐protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza
  publication-title: The Journal of Infectious Diseases
– ident: e_1_2_4_4_1
  doi: 10.3390/molecules25092076
– ident: e_1_2_4_9_1
  doi: 10.1016/j.fct.2020.111521
– ident: e_1_2_4_3_1
  doi: 10.1016/j.mehy.2020.110102
– volume: 22
  start-page: 334
  issue: 4
  year: 2019
  ident: e_1_2_4_13_1
  article-title: Immunoregulatory and anti‐inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review
  publication-title: Iranian Journal of Basic Medical Sciences
  contributor:
    fullname: Zeinali M.
– ident: e_1_2_4_2_1
  doi: 10.1155/2017/1702967
– ident: e_1_2_4_6_1
  doi: 10.1186/s12931-018-0766-3
– ident: e_1_2_4_11_1
  doi: 10.1086/656044
– ident: e_1_2_4_10_1
  doi: 10.3390/antiox9060518
– ident: e_1_2_4_5_1
  doi: 10.1016/j.arcmed.2020.04.019
– ident: e_1_2_4_12_1
  doi: 10.1016/j.lfs.2019.116794
– ident: e_1_2_4_7_1
  doi: 10.1002/jcb.26335
– ident: e_1_2_4_8_1
  doi: 10.1111/bph.15157
SSID ssj0002964
Score 2.4008899
Snippet The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel...
The current COVID-19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel...
Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e13718
SubjectTerms COVID‐19
crocin
NF‐κB
Nrf2
PPARγ
SARS‐CoV2
SummonAdditionalLinks – databaseName: Wiley Online Library
  dbid: DR2
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LatwwFL0M2aSbtklfTtMgaOmi4GE8kmUZsklnMiSBTKHMlGyK0ct0aGKHjLNIVvmEfmO_JFfyI5kECg3Y2NiykHWvpHPtoyOATyIfMplgmKrQn0JmIxUqYfNQMBwvRC60zt185-MpP5izo5P4pAe77VyYWh-i--DmWobvr10Dl2p5v5HnSvcjin0rdsB4dHyu8fc77Sj3P7HmL8Yhhnms0Sb1NJ7u0dXR6BHEfMyUvI9g_RA0eQE_28LXzJPf_ctK9fX1A13Hp77dS3jeYFOyVzvTBvRssQnBeGEr8pk0AqKnZNrq92_CejutefkKZodupkl5Vhq3IFh5cUVkYXCvFn9v_qAbo-ed1dfPy8pRlDCrMidYL3pRENxG334cjjFtlJKO_f4a5pP92eggbJZsCDXGeSJkJrEqTQ01PGZWKqk1l5qLmElJUyHTRGKElvJhKk3MKcZDVA94nkhjB8JIRt_AWlEW9h2QAdWpEYM4VxZRpcG4MBoqHkcUAZiwVgXwsTVddl4rc2RdRIO1l_naC2C7tWrWtM5lhrBPJAKBMg_gbW3gLgvqJAsRNQWQrJi-S-D0uFfvFItfXpcbg22H-AL44i37j1JlR5OvI3-29T-J38OzoaPUeL7lNqxVF5f2A2KiSu14378FA7EKew
  priority: 102
  providerName: Wiley-Blackwell
Title Immunomodulatory and anti‐inflammatory potential of crocin in COVID‐19 treatment
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjfbc.13718
https://www.ncbi.nlm.nih.gov/pubmed/33817822
https://www.proquest.com/docview/2508780206
https://pubmed.ncbi.nlm.nih.gov/PMC8250063
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50vYgHFV_VVQp6ErpumzZNT4KriwoqiK9byau46Lardg968if4G_0lTrLt-gIPQgulDWWSmWa-Sb_MAGyxLAh5jGGqQHvyQu0LTzCdeSxEf8EyJmVm9jufnNLDy_D4JrqpFtyeKlplPSfaiVoV0qyR76CrZjFDcEN3Bw-eqRpl_q5WJTQmYYqwKGANmOqcXR3tV3lILWUnE7Llk9hU9fjqeX7Byd-syK9o1bqb7iyktaAjlslda1iKlnz5kcPx_z2Zg5lrLdx67X4eJnS-ABdHZrNI0S-UqelVPD67PFd4lr331ze0RDSe_uj-oCgNy4jfu0XmYndlL3fxsKOCbf3EHRPYF-Gye3DROfSqqguexFCNeaGKtUgSRRSNQs0Fl5JySVkUck4SxpOYY5CV0CDhKqIEQxoi2zSLudJtpnhIlqCRF7leAbdNZKJYO8qERmCoMLTzA0EjnyCGYloLBzZrjaSDUXKNdByUoN5SqzcHmvU4ptUH9pR-DqIDyyO9jV9BTNZBBD4OxN80Om5gUmp_f5L3bm1qbYyXDWhzYNvq_g-p0uPuXsderf4t3xpMB4YHY0mSTWiUj0O9jkCmFBuVtW4glD8PPgBayft6
link.rule.ids 230,315,783,787,888,1378,27936,27937,38528,43907,46306,46730
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2isGjVRUGlJZRHpLJCyjSJE8dZIXVgNEN5bIaWXeRXxIhOMgxh0a74BL6RL-m18-AlsaiUSFFiRbav43uOc3wvwA7Lw4gnSFMFjicv0oHwBNO5xyL0FyxnUuZmv_PxCR2eRYfn8Xmz4HbdyCrbOdFO1KqUZo38G7pqljAEN3RvduWZrFHm72qTQuMNLKFj9ZF8LfVPf472mzikVrKTC9kLSGKyejz2PC_g5EtV5GO0at3N4ANkbUVrlcll76YSPfn3WQzH_2_JMrz_pYXbrt2vwIIuPsJ4ZDaLlNNSmZxe5fyPywuFZzW5v73DkYiDZ1rfn5WVURnx326Zu9hcOSlcPGyvYNkgdTsB-yqcDQ7G_aHXZF3wJFI15kUq0SJNFVE0jjQXXErKJWVxxDlJGU8TjiQrpWHKVUwJUhoifZonXGmfKR6RT7BYlIVeA9cnMlXMj3OhERgqpHZBKGgcEMRQTGvhwNfWItmsDq6RdaQE7ZZZuzmw0fZj1nxg19lDJzrwubZb9wpiog4i8HEgeWLRroAJqf30STG5sKG1kS8b0ObArrX9K7XKDgff-_Zq_fX6bcPb4fj4KDsanfz4Au9Co4mxgskNWKzmN3oTQU0ltpqR-w9Pd_14
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UCuqL1XqLrTqg-CBk2exMJhPoi-66dKuuIq30pYS54qJNljZ90Cd_Qn-jv8Qzk4tdC4JCAiGZDJM5czLfSb7zDcAz4UZMZhimKhxPMbOJipWwLhYM5wvhhNbO5zu_m_PdA7Z3mB6uwU6XC9PoQ_Qf3LxnhPe1d_ClcRed3Ck9SCi-W6_AVcYR-npI9PG3eJT_odgQGNMY4zzWipMGHk9_7-p0dAljXqZKXoSwYQ6absBR1_qGevJlcFargf7-h7Dj_z7eLbjZglPyshlNt2HNlpsQTRa2Js9JqyD6lcw7Af9NuN7lNZ_egf2ZTzWpjivjVwSrTr4RWRrc68XPH-c4jnHoHTfnl1XtOUpYVeUI9otelAS38ftPswmWTXLS09_vwsH09f54N27XbIg1BnoiZiazKs8NNTxlViqpNZeai5RJSXMh80xiiJbzUS5NyikGRFQPucuksUNhJKP3YL2sSvsAyJDq3Ihh6pRFWGkwMExGiqcJRQQmrFURPO1MVywbaY6iD2mw94rQexFsd1YtWvc8LRD3iUwgUuYR3G8M3FdBvWYhwqYIshXT9wW8IPfqlXLxOQhzY7TtIV8EL4Jl_9KqYm_6ahyOHv5L4Sdw7cNkWrydzd9swY2Rp9cE7uU2rNcnZ_YR4qNaPQ5u8Atd2w1C
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunomodulatory+and+anti%E2%80%90inflammatory+potential+of+crocin+in+COVID%E2%80%9019+treatment&rft.jtitle=Journal+of+food+biochemistry&rft.au=Ghasemnejad%E2%80%90Berenji%2C+Morteza&rft.date=2021-05-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=0145-8884&rft.eissn=1745-4514&rft.volume=45&rft.issue=5&rft_id=info:doi/10.1111%2Fjfbc.13718&rft_id=info%3Apmid%2F33817822&rft.externalDBID=PMC8250063
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0145-8884&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0145-8884&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0145-8884&client=summon